Literature DB >> 10619866

Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.

D Y Jo1, S Rafii, T Hamada, M A Moore.   

Abstract

Stromal cell-derived factor-1 (SDF-1) provides a potent chemotactic stimulus for CD34(+) hematopoietic cells. We cultured mobilized peripheral blood (PB) and umbilical cord blood (CB) for up to 5 weeks and examined the migratory activity of cobblestone area-forming cells (CAFCs) and long-term culture-initiating cells (LTC-ICs) in a transwell assay. In this system, SDF-1 or MS-5 marrow stromal cells placed in the lower chamber induced transmembrane and transendothelial migration by 2- and 5-week-old CAFCs and LTC-ICs in 3 hours. Transmigration was blocked by preincubation of input CD34(+) cells with antibody to CXCR4. Transendothelial migration of CB CAFCs and LTC-ICs was higher than that of PB. We expanded CD34(+) cells from CB in serum-free medium with thrombopoietin, flk-2 ligand, and c-kit ligand, with or without IL-3 and found that CAFCs cultured in the absence of IL-3 had a chemotactic response equivalent to noncultured cells, even after 5 weeks. However, addition of IL-3 to the culture reduced this response by 20-50%. These data indicate that SDF-1 induces chemotaxis of primitive hematopoietic cells signaling through CXCR4 and that the chemoattraction could be downmodulated by culture ex vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10619866      PMCID: PMC382585          DOI: 10.1172/JCI7954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.

Authors:  O I Gan; B Murdoch; A Larochelle; J E Dick
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.

Authors:  M Engelhardt; R Kumar; J Albanell; R Pettengell; W Han; M A Moore
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

4.  Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.

Authors:  C J Hogan; E J Shpall; O McNulty; I McNiece; J E Dick; L D Shultz; G Keller
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

5.  Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood.

Authors:  W Piacibello; F Sanavio; L Garetto; A Severino; D Bergandi; J Ferrario; F Fagioli; M Berger; M Aglietta
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay.

Authors:  J C Wang; M Doedens; J E Dick
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

7.  In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.

Authors:  C H Kim; H E Broxmeyer
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

8.  Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.

Authors:  C J Hogan; E J Shpall; I McNiece; G Keller
Journal:  Biol Blood Marrow Transplant       Date:  1997-11       Impact factor: 5.742

9.  The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.

Authors:  M D'Apuzzo; A Rolink; M Loetscher; J A Hoxie; I Clark-Lewis; F Melchers; M Baggiolini; B Moser
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

10.  Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture.

Authors:  M Bhatia; D Bonnet; U Kapp; J C Wang; B Murdoch; J E Dick
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

View more
  61 in total

1.  Umbilical cord blood: an expandable resource.

Authors:  M A Moore
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  CXCR4 gene transfer prevents pressure overload induced heart failure.

Authors:  Thomas J Larocca; Dongtak Jeong; Erik Kohlbrenner; Ahyoung Lee; Jiqiu Chen; Roger J Hajjar; Sima T Tarzami
Journal:  J Mol Cell Cardiol       Date:  2012-06-03       Impact factor: 5.000

4.  Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.

Authors:  Chad M Novince; Amy J Koh; Megan N Michalski; Julie T Marchesan; Jason Wang; Younghun Jung; Janice E Berry; Matthew R Eber; Thomas J Rosol; Russell S Taichman; Laurie K McCauley
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

Review 5.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

6.  CXCR4 modulates contractility in adult cardiac myocytes.

Authors:  Robert T Pyo; Jinliang Sui; Ashwini Dhume; Julieta Palomeque; Burns C Blaxall; George Diaz; James Tunstead; Diomedes E Logothetis; Roger J Hajjar; Alison D Schecter
Journal:  J Mol Cell Cardiol       Date:  2006-09-28       Impact factor: 5.000

7.  Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.

Authors:  Krishna Reddy; Zhichao Zhou; Shu-Fang Jia; Tim H Lee; Jaime Morales-Arias; Ying Cao; Eugenie S Kleinerman
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

8.  Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury.

Authors:  Enrico Velardi; Jennifer J Tsai; Stefan Radtke; Kirsten Cooper; Kimon V Argyropoulos; Shieh Jae-Hung; Lauren F Young; Amina Lazrak; Odette M Smith; Sophie Lieberman; Fabiana Kreines; Yusuke Shono; Tobias Wertheimer; Robert R Jenq; Alan M Hanash; Prema Narayan; Zhenmin Lei; Malcolm A Moore; Hans-Peter Kiem; Marcel R M van den Brink; Jarrod A Dudakov
Journal:  Nat Med       Date:  2018-01-08       Impact factor: 53.440

9.  Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10.

Authors:  Suman Kanji; Manjusri Das; Reeva Aggarwal; Jingwei Lu; Matthew Joseph; Sujit Basu; Vincent J Pompili; Hiranmoy Das
Journal:  Stem Cell Res       Date:  2013-11-15       Impact factor: 2.020

10.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.

Authors:  Jean-Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Paul J Simmons; Linda J Bendall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.